Literature DB >> 7904140

Antineoplastic drug resistance and breast cancer.

C S Morrow1, K H Cowan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7904140     DOI: 10.1111/j.1749-6632.1993.tb17220.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

Review 1.  Nuclear medicine at the crossroads.

Authors:  H W Strauss
Journal:  Eur J Nucl Med       Date:  1996-06

2.  Expression of HIF-2alpha/EPAS1 in hepatocellular carcinoma.

Authors:  Gassimou Bangoura; Lian-Yue Yang; Gen-Wen Huang; Wei Wang
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

3.  Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.

Authors:  R Lacave; F Coulet; S Ricci; E Touboul; A Flahault; J G Rateau; D Cesari; J P Lefranc; J F Bernaudin
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

4.  Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer.

Authors:  J Y Pierga; C Lainé-Bidron; P Beuzeboc; P De Crémoux; P Pouillart; H Magdelénat
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Unexpected Lower Expression of Oncoprotein Gankyrin in Drug Resistant ABCG2 Overexpressing Breast Cancer Cell Lines

Authors:  Taheri Taheri; Khadijeh Jamialahmadi; Fatemeh Khadijeh
Journal:  Asian Pac J Cancer Prev       Date:  2017-12-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.